Foundayo Review: Eli Lilly's New Weight Loss Pill Rated
Eli Lilly's Foundayo (orforglipron) is the first oral GLP-1 approved for weight loss. We review pricing, efficacy, side effects, and how to get it.
Independent, evidence-based reviews of health products, fitness trackers, nutrition guides, mental health apps, and wellness programs. No sponsored content. No paid placements.
Eli Lilly's Foundayo (orforglipron) is the first oral GLP-1 approved for weight loss. We review pricing, efficacy, side effects, and how to get it.
Medicare will cover GLP-1 weight loss drugs starting July 2026 through the Bridge Program. Here is everything seniors need to know about eligibility, costs, and enrollment.
The Mediterranean diet is one of the healthiest eating patterns on the planet, but it does not have to be expensive. Here is how to follow it without breaking the bank.
We tested and compared the top online weight loss programs available today, from GLP-1 telehealth services to structured coaching platforms.
A detailed comparison of the leading telehealth platforms prescribing GLP-1 medications, including pricing, prescriber quality, and patient support.
Both contain semaglutide, but Ozempic and Wegovy differ in dosing, approval, insurance coverage, and cost. We break down every difference.
Insurance coverage for GLP-1 drugs is evolving rapidly. We mapped out what major insurers cover and how to navigate prior authorization.
Compounded semaglutide is significantly cheaper, but is it safe? We examine the FDA stance, pharmacy standards, and real-world safety data.
Starting a GLP-1 medication is a major health decision. These ten questions will help you evaluate providers and protect your health.